Studies on the underlying mechanisms demonstrate that HER3 signaling promotes cancer progression mainly through influencing two aspects of cancer biology, mainly by enhancing metastatic potential of tumor cells and causing treatment failures in cancer therapy [14–16]. This evidence concerns the gene ERBB3 and neoplasm.